CoChat

Multitracer model for staging cortical amyloid deposition using PET imaging

Open access
Collij, Lyduine E., Heeman, Fiona, Salvadó, Gemma, Ingala, Silvia, Altomare, Daniele, de Wilde, Arno, Konijnenberg, Elles, van Buchem, Marieke, Yaqub, Maqsood, Markiewicz, Pawel, Golla, Sandeep S.V., Wottschel, Viktor, Wink, Alle Meije, Visser, Pieter Jelle, Teunissen, Charlotte E., Lammertsma, Adriaan A., Scheltens, Philip, van der Flier, Wiesje M., Boellaard, Ronald, van Berckel, Bart N.M., Molinuevo, José Luis, Gispert, Juan Domingo, Schmidt, Mark E., Barkhof, Frederik, Lopes Alves, Isadora, on behalf of the AMYPAD Consortium, for the ALFA Study, for the Alzheimer's Disease Neuroimaging Initiative, Arenaza-Urquijo, Eider M, Beteta, Annabella, Brugulat-Serrat, Anna, Cacciaglia, Raffaele, Boccagni, Alba Cañas, Bodien, Yelena G., Crous-Bou, Marta, Deulofeu, Carme, Dominguez, Ruth, Fauria, Karine, Falcon, Carles, Félez-Sánchez, Marta, González de Echavarri, Jose María, Grau-Rivera, Oriol, Hernández, Laura, Huesa, Gema, Huguet, Jordi, LeÓn, MarÍa, Marne, Paula, Menchón, Tania, Milà-Alomà, Marta, Operto, Grégory, Minguillon, Carolina, Pascual, Maria, Polo, Albina, Pradas, Sandra, Sala-Vila, Aleix, Sánchez-Benavides, Gonzalo, Shekari, Mahnaz, Soteras, Anna, Suárez-Calvet, Marc, Tenas, Laia, Vilanova, Marc, Vilor-Tejedor, Natalia · 2020 · Neurology
Cited by 98

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Objective To develop and evaluate a model for staging cortical amyloid deposition using PET with high generalizability. Methods Three thousand twenty-seven individuals (1,763 cognitively unimpaired [CU], 658 impaired, 467 with Alzheimer disease [AD] dementia, 111 with non-AD dementia, and 28 with missing diagnosis) from 6 cohorts (European Medical Information Framework for AD, Alzheimer9s and Family, Alzheimer9s Biomarkers in Daily Practice, Amsterdam Dementia Cohort, Open Access Series of Imaging Studies [OASIS]-3, Alzheimer’s Disease Neuroimaging Initiative [ADNI]) who underwent amyloid PET were retrospectively included; 1,049 individuals had follow-up scans. With application of dataset-specific cutoffs to global standard uptake value ratio (SUVr) values from 27 regions, single-tracer and pooled multitracer regional rankings were constructed from the frequency of abnormality across 400 CU individuals (100 per tracer). The pooled multitracer ranking was used to create a staging model consisting of 4 clusters of regions because it displayed a high and consistent correlation with each single-tracer ranking. Relationships between amyloid stage, clinical variables, and longitudinal cognitive decline were investigated. Results SUVr abnormality was most frequently observed in cingulate, followed by orbitofrontal, precuneal, and insular cortices and then the associative, temporal, and occipital regions. Abnormal amyloid levels based on binary global SUVr classification were observed in 1.0%, 5.5%, 17.9%, 90.0%, and 100.0% of individuals in stage 0 to 4, respectively. Baseline stage predicted decline in Mini-Mental State Examination (MMSE) score (ADNI: n = 867, F = 67.37, p < 0.001; OASIS: n = 475, F = 9.12, p < 0.001) and faster progression toward an MMSE score ≤25 (ADNI: n = 787, hazard ratio [HR]stage1 2.00, HRstage2 3.53, HRstage3 4.55, HRstage4 9.91, p < 0.001; OASIS: n = 469, HRstage4 4.80, p < 0.001). Conclusion The pooled multitracer staging model successfully classified the level of amyloid burden in >3,000 individuals across cohorts and radiotracers and detects preglobal amyloid burden and distinct risk profiles of cognitive decline within globally amyloid-positive individuals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000010256

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 98

Metadata

Authors
Collij, L. E., Heeman, F., Salvadó, G., Ingala, S., Altomare, D., de Wilde, A., Konijnenberg, E., van Buchem, M., Yaqub, M., Markiewicz, P., Golla, S. S. V., Wottschel, V., Wink, A. M., Visser, P. J., Teunissen, C. E., Lammertsma, A. A., Scheltens, P., van der Flier, W. M., Boellaard, R., van Berckel, B. N. M., Molinuevo, J. L., Gispert, J. D., Schmidt, M. E., Barkhof, F., Lopes Alves, I., on behalf of the AMYPAD Consortium, for the ALFA Study, F. T. A. D. N. I., Arenaza-Urquijo, E. M., Beteta, A., Brugulat-Serrat, A., Cacciaglia, R., Boccagni, A. C., Bodien, Y. G., Crous-Bou, M., Deulofeu, C., Dominguez, R., Fauria, K., Falcon, C., Félez-Sánchez, M., González de Echavarri, J. M., Grau-Rivera, O., Hernández, L., Huesa, G., Huguet, J., LeÓn, M., Marne, P., Menchón, T., Milà-Alomà, M., Operto, G., Minguillon, C., Pascual, M., Polo, A., Pradas, S., Sala-Vila, A., Sánchez-Benavides, G., Shekari, M., Soteras, A., Suárez-Calvet, M., Tenas, L., Vilanova, M., & Vilor-Tejedor, N.
Venue
Neurology
Published
2020-09-15
Volume
95
Issue
11
Pages
e1538-e1553
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W3042249111
Cited by
98
References
12
FWCI
8.62
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multitracer model for staging cortical amyloid deposition using PET imaging. https://app.cochat.ai/papers/10.1212/wnl.0000000000010256
The paper
Collij, L. E., Heeman, F., Salvadó, G., Ingala, S., Altomare, D., de Wilde, A., Konijnenberg, E., van Buchem, M., Yaqub, M., Markiewicz, P., Golla, S. S. V., Wottschel, V., Wink, A. M., Visser, P. J., Teunissen, C. E., Lammertsma, A. A., Scheltens, P., van der Flier, W. M., Boellaard, R., . . . Vilor-Tejedor, N. (2020). Multitracer model for staging cortical amyloid deposition using PET imaging. Neurology. https://doi.org/10.1212/wnl.0000000000010256

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.